Pfizer Gets FDA Approval for Expanded Use of Breast-Cancer Treatment Tukysa
Pfizer Inc PFE
News
Pfizer’s TUKYSA Regimen Receives FDA Approval as Front-Line Maintenance Treatment for HER2+ Metastatic Breast Cancer
Astellas Highlights Data Advancing Cancer Care and Innovation for Patients with Hard-to-Treat Cancers at ESMO 2026
Pfizer Declares Fourth-Quarter 2026 Dividend
Vaxcyte Reports Bacterial-Infection Vaccine Met Primary Endpoints in Phase 3 Trial
Pfizer’s LITFULO Significantly Improved Facial and Total Body Repigmentation in Patients with Nonsegmental Vitiligo
Pfizer's Tilrekimig Shows Significant Skin Clearance in Phase 2 Atopic Dermatitis Study
Pfizer Advances Today’s Cancer Care and Tomorrow's Potential Breakthroughs at ESMO
Pfizer Invites Public to View and Listen to Webcast of November 3 Conference Call with Analysts
Pfizer Invites Public to Listen to Webcast of Pfizer Discussion at Healthcare Conference
Pfizer Invites Public to Listen to Webcast of Pfizer Discussion at Healthcare Conference
FDA Approves Seasonal Covid-19 Vaccines From Moderna, Pfizer, BioNTech, Novavax — Update
FDA Approves Seasonal Covid-19 Vaccines From Moderna, Pfizer, BioNTech
Pfizer and BioNTech Receive U.S. FDA Approval for XFG-adapted COVID-19 Vaccine
Pfizer on Pace for Largest Percent Increase Since November 2025 — Data Talk
Valneva Shares Climb After Lyme Disease Vaccine Receives EMA Application Acceptance
Pfizer and Valneva’s Lyme Disease Vaccine Candidate Marketing Authorization Application Validated by European Medicines Agency
Pfizer Currently Up Eight Days Straight, On Pace for Longest Winning Streak Since April 2021 — Data Talk
NYSE Content Update: ADI to Make NYSE Trading Debut After Spin-Off
Pfizer Logs Mixed 2Q on Oncology Growth, Covid-19 Declines
United States